Business

Novo Nordisk Stock Plummets

Updated 2026-08-27 08:55 UTC 1 source Negative

Ozempic maker Novo Nordisk's stock price has dropped 70% from its peak, leading to a downgrade by Deutsche Bank. Wall Street analysts remain cautious about advising investors to sell the stock.

Coverage timeline — 1 article

MarketWatch

Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak

While Ozempic maker Novo Nordisk has fallen on tough times, Wall Street analysts have still been reluctant to advise investors to sell the stock, until Deutsche Bank lowered the boom on Thursday.

2026-08-27 08:37 UTC